Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H5QU
|
||||
Former ID |
DNC013613
|
||||
Drug Name |
ZNCCNCSSKWCRDHSRCC
|
||||
Indication | Discovery agent | Investigative | [529000] | ||
Structure |
Download2D MOL |
||||
Formula |
C79H117N31O26S6
|
||||
Canonical SMILES |
C1CC(=O)NC1C(=O)NC(CC(=O)N)C(=O)NC2CSSCC3C(=O)NC(C(=O)N<br />C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC4CSSCC(C(=O)NC(C(=O)NC<br />(CSSCC(NC4=O)C(=O)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=<br />O)N3)CC5=CNC6=CC=CC=C65)CCCCN)CO)CO)CC(=O)N)NC2=O)CCCNC<br />(=N)N)CO)CC7=CN=CN7)CC(=O)O)CCCNC(=N)N
|
||||
InChI |
1S/C79H117N31O26S6/c80-14-4-3-9-38-61(120)97-42(17-34-22-91-37-8-2-1-7-36(34)37)65(124)107-51-28-139-142-32-55(109-67(126)44(19-56(81)114)99-64(123)41-12-13-58(116)93-41)77(136)110-52-29-140-141-31-54(76(135)105-50(60(83)119)27-137-138-30-53(108-68(127)45(20-57(82)115)100-74(52)133)75(134)104-49(26-113)72(131)103-48(25-112)71(130)94-38)106-63(122)40(11-6-16-90-79(86)87)95-70(129)47(24-111)102-66(125)43(18-35-23-88-33-92-35)98-69(128)46(21-59(117)118)101-62(121)39(96-73(51)132)10-5-15-89-78(84)85/h1-2,7-8,22-23,33,38-55,91,111-113H,3-6,9-21,24-32,80H2,(H2,81,114)(H2,82,115)(H2,83,119)(H,88,92)(H,93,116)(H,94,130)(H,95,129)(H,96,132)(H,97,120)(H,98,128)(H,99,123)(H,100,133)(H,101,121)(H,102,125)(H,103,131)(H,104,134)(H,105,135)(H,106,122)(H,107,124)(H,108,127)(H,109,126)(H,110,136)(H,117,118)(H4,84,85,89)(H4,86,87,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-/m0/s1
|
||||
InChIKey |
ZZZNHYZYRLIYMB-JPPSNFOMSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 4 subunit alpha | Target Info | Inhibitor | [529000] | |
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.